Cargando…
Validation of the Friedewald Formula in Patients with Metabolic Syndrome
Currently, the Friedewald formula (FF) is the main method for evaluating low-density lipoprotein cholesterol (LDL-c). Recently, many limitations have emerged regarding its use, including patients with triglyceride levels ≥400 mg/dL, diabetes mellitus, and kidney or hepatic chronic diseases. We analy...
Autores principales: | Knopfholz, José, Disserol, Caio César Diniz, Pierin, Andressa Jardim, Schirr, Fernanda Letícia, Streisky, Larissa, Takito, Lilian Lumi, Massucheto Ledesma, Patrícia, Faria-Neto, José Rocha, Olandoski, Marcia, da Cunha, Claudio Leinig Pereira, Bandeira, Antonio Milton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941209/ https://www.ncbi.nlm.nih.gov/pubmed/24672715 http://dx.doi.org/10.1155/2014/261878 |
Ejemplares similares
-
Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
por: Hong, Jinyoung, et al.
Publicado: (2023) -
A Leap above Friedewald Formula for Calculation of Low-Density Lipoprotein-Cholesterol
por: Kapoor, Reema, et al.
Publicado: (2015) -
Is Friedewald formula a good estimation for low density lipoprotein level in Iranian population?
por: Boshtam, Maryam, et al.
Publicado: (2012) -
Development of a Modified Friedewald’s Formula to Calculate Low-Density Lipoprotein in an Iranian Population
por: Sobhani, Seyed Alireza, et al.
Publicado: (2023) -
Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol
por: Briers, Pieter-Jan, et al.
Publicado: (2021)